| ENSG00000178440.5 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006520659 |
Resistant |
| ENSG00000180139.10 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023154511 |
Resistant |
| ENSG00000182310.8 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006690757 |
Resistant |
| ENSG00000188185.7 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016400526 |
Resistant |
| ENSG00000197099.4 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014754971 |
Resistant |
| ENSG00000205037.2 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018943842 |
Resistant |
| ENSG00000205913.2 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033921563 |
Resistant |
| ENSG00000212163.2 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031944398 |
Resistant |
| ENSG00000213742.2 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033992758 |
Resistant |
| ENSG00000213793.3 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016261067 |
Resistant |
| ENSG00000213971.3 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003862247 |
Resistant |
| ENSG00000214353.3 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006035042 |
Resistant |
| ENSG00000214401.4 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025528351 |
Resistant |
| ENSG00000219665.4 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021839051 |
Resistant |
| ENSG00000223478.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001871847 |
Resistant |
| ENSG00000223882.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003865286 |
Resistant |
| ENSG00000224635.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039045213 |
Resistant |
| ENSG00000224746.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037893232 |
Resistant |
| ENSG00000224888.3 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004087338 |
Resistant |
| ENSG00000224914.2 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011113309 |
Resistant |
| ENSG00000225527.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00879308 |
Resistant |
| ENSG00000225721.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029424749 |
Resistant |
| ENSG00000225839.2 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018824471 |
Resistant |
| ENSG00000226047.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027992519 |
Resistant |
| ENSG00000226803.3 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025685729 |
Resistant |
| ENSG00000227155.3 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010544461 |
Resistant |
| ENSG00000227456.3 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031978338 |
Resistant |
| ENSG00000227627.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006711773 |
Resistant |
| ENSG00000228237.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011754949 |
Resistant |
| ENSG00000228302.2 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039298985 |
Resistant |
| ENSG00000228802.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037056166 |
Resistant |
| ENSG00000230555.2 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047035212 |
Resistant |
| ENSG00000231025.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012291925 |
Resistant |
| ENSG00000231119.2 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004249271 |
Resistant |
| ENSG00000231607.4 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03686379 |
Resistant |
| ENSG00000231728.2 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000400446 |
Resistant |
| ENSG00000231842.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001087698 |
Resistant |
| ENSG00000231865.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027855031 |
Resistant |
| ENSG00000232593.2 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006177077 |
Resistant |
| ENSG00000232640.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004670544 |
Resistant |
| ENSG00000232648.3 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000525224 |
Resistant |
| ENSG00000233483.2 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043295105 |
Resistant |
| ENSG00000233852.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034947344 |
Resistant |
| ENSG00000234019.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004053079 |
Resistant |
| ENSG00000234327.3 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001187077 |
Resistant |
| ENSG00000234494.3 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001762395 |
Resistant |
| ENSG00000235530.2 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011276465 |
Resistant |
| ENSG00000235560.3 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032511624 |
Resistant |
| ENSG00000235802.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040948766 |
Resistant |
| ENSG00000236537.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023152447 |
Resistant |
| ENSG00000237594.2 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020662597 |
Resistant |
| ENSG00000237605.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003809768 |
Resistant |
| ENSG00000237718.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00804131 |
Resistant |
| ENSG00000238198.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045984037 |
Resistant |
| ENSG00000239377.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01681385 |
Resistant |
| ENSG00000240211.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008553021 |
Resistant |
| ENSG00000240549.2 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04658948 |
Resistant |
| ENSG00000242622.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041886674 |
Resistant |
| ENSG00000243433.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000433025 |
Resistant |
| ENSG00000246145.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000359042 |
Resistant |
| ENSG00000246250.2 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007175067 |
Resistant |
| ENSG00000247137.4 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008289784 |
Resistant |
| ENSG00000248773.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023836958 |
Resistant |
| ENSG00000249846.2 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027833306 |
Resistant |
| ENSG00000250592.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038159102 |
Resistant |
| ENSG00000253653.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04285798 |
Resistant |
| ENSG00000253865.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028293652 |
Resistant |
| ENSG00000254428.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025758191 |
Resistant |
| ENSG00000254855.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047189573 |
Resistant |
| ENSG00000254929.2 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044428914 |
Resistant |
| ENSG00000254964.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003785863 |
Resistant |
| ENSG00000255321.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049789197 |
Resistant |
| ENSG00000255989.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011333443 |
Resistant |
| ENSG00000256973.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045387917 |
Resistant |
| ENSG00000257303.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030593976 |
Resistant |
| ENSG00000257742.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012820395 |
Resistant |
| ENSG00000258378.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042716832 |
Resistant |
| ENSG00000258725.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042216398 |
Resistant |
| ENSG00000258851.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004788199 |
Resistant |
| ENSG00000259083.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024246171 |
Resistant |
| ENSG00000259118.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002781384 |
Resistant |
| ENSG00000259364.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024935022 |
Resistant |
| ENSG00000259656.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033271146 |
Resistant |
| ENSG00000259768.3 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040465299 |
Resistant |
| ENSG00000259901.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044356292 |
Resistant |
| ENSG00000259959.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024065691 |
Resistant |
| ENSG00000260005.2 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027764276 |
Resistant |
| ENSG00000260196.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000382262 |
Resistant |
| ENSG00000260261.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01019173 |
Resistant |
| ENSG00000260423.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000270836 |
Resistant |
| ENSG00000260447.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025270856 |
Resistant |
| ENSG00000260853.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041245779 |
Resistant |
| ENSG00000261131.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007976587 |
Resistant |
| ENSG00000261254.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000695132 |
Resistant |
| ENSG00000261266.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01369591 |
Resistant |
| ENSG00000261430.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026465227 |
Resistant |
| ENSG00000261441.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044369299 |
Resistant |
| ENSG00000261476.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003514559 |
Resistant |
| ENSG00000261481.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045059836 |
Resistant |
| ENSG00000261777.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0408195 |
Resistant |
| ENSG00000262228.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00000851 |
Resistant |
| ENSG00000262692.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036613925 |
Resistant |
| ENSG00000263499.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042211245 |
Resistant |
| ENSG00000264808.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000332216 |
Resistant |
| ENSG00000264860.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026279651 |
Resistant |
| ENSG00000265656.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038915104 |
Resistant |
| ENSG00000266120.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018891912 |
Resistant |
| ENSG00000266783.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015999316 |
Resistant |
| ENSG00000266926.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016568431 |
Resistant |
| ENSG00000266983.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042081277 |
Resistant |
| ENSG00000267096.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0469486 |
Resistant |
| ENSG00000267167.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018079843 |
Resistant |
| ENSG00000267244.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006977765 |
Resistant |
| ENSG00000267274.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036214937 |
Resistant |
| ENSG00000267479.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042649477 |
Resistant |
| ENSG00000267613.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002354178 |
Resistant |
| ENSG00000267655.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032711308 |
Resistant |
| ENSG00000268613.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000379705 |
Resistant |
| ENSG00000268970.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0000978 |
Resistant |
| ENSG00000269038.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001997528 |
Resistant |
| ENSG00000269107.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000850504 |
Resistant |
| ENSG00000269321.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007325066 |
Resistant |
| ENSG00000269444.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034173748 |
Resistant |
| ENSG00000269646.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00868006 |
Resistant |
| ENSG00000269836.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040422549 |
Resistant |
| ENSG00000270081.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015319749 |
Resistant |
| ENSG00000270109.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040911962 |
Resistant |
| ENSG00000270159.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007737863 |
Resistant |
| ENSG00000270195.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003890616 |
Resistant |
| ENSG00000270482.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044516958 |
Resistant |
| ENSG00000271185.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022999539 |
Resistant |
| ENSG00000272092.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009429424 |
Resistant |
| ENSG00000272109.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029873004 |
Resistant |
| ENSG00000272211.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019819848 |
Resistant |
| ENSG00000272219.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028547182 |
Resistant |
| ENSG00000272377.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025590589 |
Resistant |
| ENSG00000272635.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039493253 |
Resistant |
| ENSG00000272792.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006165969 |
Resistant |
| ENSG00000272800.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037030345 |
Resistant |
| ENSG00000272989.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012043553 |
Resistant |
| ENSG00000273162.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002656298 |
Resistant |
| ENSG00000273281.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025734352 |
Resistant |
| ENSG00000273308.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044787478 |
Resistant |
| ENSG00000273428.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012310513 |
Resistant |
| ENSG00000174171.4 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.028055433 |
Resistant |
| ENSG00000175701.6 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.03850093 |
Resistant |
| ENSG00000185186.4 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.028781408 |
Resistant |
| ENSG00000189419.5 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.042575649 |
Resistant |
| ENSG00000204934.6 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.020072603 |
Resistant |
| ENSG00000205559.3 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.043475429 |
Resistant |
| ENSG00000206417.4 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.019968601 |
Resistant |
| ENSG00000212978.5 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.010302671 |
Resistant |
| ENSG00000217258.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.004966398 |
Resistant |
| ENSG00000223393.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.045323487 |
Resistant |
| ENSG00000223462.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.012434574 |
Resistant |
| ENSG00000223711.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.004281946 |
Resistant |
| ENSG00000224794.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.032890599 |
Resistant |
| ENSG00000224857.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.010675552 |
Resistant |
| ENSG00000224883.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.045378303 |
Resistant |
| ENSG00000224965.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.041203855 |
Resistant |
| ENSG00000225703.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.033961747 |
Resistant |
| ENSG00000226291.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.025398698 |
Resistant |
| ENSG00000226386.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.018499446 |
Resistant |
| ENSG00000226505.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.034637595 |
Resistant |
| ENSG00000226904.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.026799039 |
Resistant |
| ENSG00000226957.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.028962706 |
Resistant |
| ENSG00000227076.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.02930663 |
Resistant |
| ENSG00000227258.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.019418121 |
Resistant |
| ENSG00000227484.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.029832627 |
Resistant |
| ENSG00000227495.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.044169741 |
Resistant |
| ENSG00000227502.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.021619074 |
Resistant |
| ENSG00000227704.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.013421781 |
Resistant |
| ENSG00000227740.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.005412127 |
Resistant |
| ENSG00000227769.3 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.025801512 |
Resistant |
| ENSG00000227857.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.01700282 |
Resistant |
| ENSG00000228126.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.031849994 |
Resistant |
| ENSG00000228172.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.028994196 |
Resistant |
| ENSG00000229645.4 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.011276035 |
Resistant |
| ENSG00000229841.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.017939247 |
Resistant |
| ENSG00000229848.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.028734219 |
Resistant |
| ENSG00000230091.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.014553114 |
Resistant |
| ENSG00000230107.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.042159678 |
Resistant |
| ENSG00000230337.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.03484423 |
Resistant |
| ENSG00000230606.6 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.023199188 |
Resistant |
| ENSG00000230753.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.015092017 |
Resistant |
| ENSG00000230826.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.019422475 |
Resistant |
| ENSG00000231507.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.012422845 |
Resistant |
| ENSG00000231728.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.028445797 |
Resistant |
| ENSG00000231770.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.008254342 |
Resistant |
| ENSG00000231816.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.02389952 |
Resistant |
| ENSG00000231840.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.022007664 |
Resistant |
| ENSG00000231912.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.049692786 |
Resistant |
| ENSG00000232259.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.042494556 |
Resistant |
| ENSG00000233184.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.041410024 |
Resistant |
| ENSG00000233368.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.024728693 |
Resistant |
| ENSG00000233411.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.04726787 |
Resistant |
| ENSG00000233554.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.032461903 |
Resistant |
| ENSG00000233559.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.036053375 |
Resistant |
| ENSG00000233755.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.046475398 |
Resistant |
| ENSG00000233791.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.008068225 |
Resistant |
| ENSG00000233903.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.018360084 |
Resistant |
| ENSG00000234141.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.048511945 |
Resistant |
| ENSG00000234572.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.043387632 |
Resistant |
| ENSG00000234705.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.01171678 |
Resistant |
| ENSG00000234884.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.040831308 |
Resistant |
| ENSG00000235131.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.048817845 |
Resistant |
| ENSG00000235314.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.016786501 |
Resistant |
| ENSG00000235358.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.020143283 |
Resistant |
| ENSG00000236017.3 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.018585271 |
Resistant |
| ENSG00000236137.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.017022909 |
Resistant |
| ENSG00000236404.4 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.035785401 |
Resistant |
| ENSG00000236559.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.020681713 |
Resistant |
| ENSG00000236682.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.048628774 |
Resistant |
| ENSG00000236861.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.047226136 |
Resistant |
| ENSG00000236871.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.020301254 |
Resistant |
| ENSG00000237149.4 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.048593703 |
Resistant |
| ENSG00000237520.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.033137987 |
Resistant |
| ENSG00000237797.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.045947319 |
Resistant |
| ENSG00000238005.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.039069845 |
Resistant |
| ENSG00000238280.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.032756776 |
Resistant |
| ENSG00000240207.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.004534423 |
Resistant |
| ENSG00000240476.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.004795948 |
Resistant |
| ENSG00000240875.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.048615022 |
Resistant |
| ENSG00000241316.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.028838515 |
Resistant |
| ENSG00000241481.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.018479051 |
Resistant |
| ENSG00000244268.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.023449058 |
Resistant |
| ENSG00000245522.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.036403418 |
Resistant |
| ENSG00000245552.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.006422498 |
Resistant |
| ENSG00000246095.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.029738487 |
Resistant |
| ENSG00000249635.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.008675813 |
Resistant |
| ENSG00000249807.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.031242935 |
Resistant |
| ENSG00000250413.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.04718648 |
Resistant |
| ENSG00000251687.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.034300072 |
Resistant |
| ENSG00000253632.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.021704839 |
Resistant |
| ENSG00000254419.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.040613631 |
Resistant |
| ENSG00000254662.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.025047011 |
Resistant |
| ENSG00000254777.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.034731756 |
Resistant |
| ENSG00000254826.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.040532658 |
Resistant |
| ENSG00000254854.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.016856482 |
Resistant |
| ENSG00000255142.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.041030829 |
Resistant |
| ENSG00000255306.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.012357085 |
Resistant |
| ENSG00000257135.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.010573952 |
Resistant |
| ENSG00000257167.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.018093363 |
Resistant |
| ENSG00000257556.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.03859193 |
Resistant |
| ENSG00000258731.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.00317564 |
Resistant |
| ENSG00000258777.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.01816884 |
Resistant |
| ENSG00000258843.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.026176212 |
Resistant |
| ENSG00000258920.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.045277315 |
Resistant |
| ENSG00000259153.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.036526085 |
Resistant |
| ENSG00000259248.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.036517427 |
Resistant |
| ENSG00000259673.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.0042943 |
Resistant |
| ENSG00000259687.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.0242567 |
Resistant |
| ENSG00000259732.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.03860075 |
Resistant |
| ENSG00000259804.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.008590243 |
Resistant |
| ENSG00000260317.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.02096629 |
Resistant |
| ENSG00000260352.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.048442926 |
Resistant |
| ENSG00000260441.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.04025863 |
Resistant |
| ENSG00000260778.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.040052166 |
Resistant |
| ENSG00000260793.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.011482646 |
Resistant |
| ENSG00000260830.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.038278834 |
Resistant |
| ENSG00000260936.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.016237118 |
Resistant |
| ENSG00000261000.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.007290501 |
Resistant |
| ENSG00000261019.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.003183462 |
Resistant |
| ENSG00000261173.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.031770952 |
Resistant |
| ENSG00000261346.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.012801495 |
Resistant |
| ENSG00000261373.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.030953459 |
Resistant |
| ENSG00000261386.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.002696971 |
Resistant |
| ENSG00000261416.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.03399318 |
Resistant |
| ENSG00000261504.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.034527208 |
Resistant |
| ENSG00000261783.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.013806757 |
Resistant |
| ENSG00000262686.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.036250642 |
Resistant |
| ENSG00000263105.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.021331368 |
Resistant |
| ENSG00000264043.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.037377258 |
Resistant |
| ENSG00000267010.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.011749397 |
Resistant |
| ENSG00000267067.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.013442701 |
Resistant |
| ENSG00000267476.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.024255072 |
Resistant |
| ENSG00000267654.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.045387449 |
Resistant |
| ENSG00000267705.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.013735322 |
Resistant |
| ENSG00000268530.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.012235284 |
Resistant |
| ENSG00000269161.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.040094098 |
Resistant |
| ENSG00000269387.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.032650801 |
Resistant |
| ENSG00000269423.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.013890568 |
Resistant |
| ENSG00000269946.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.034012156 |
Resistant |
| ENSG00000270062.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.004207496 |
Resistant |
| ENSG00000270091.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.019350677 |
Resistant |
| ENSG00000270107.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.044149375 |
Resistant |
| ENSG00000270178.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.017423129 |
Resistant |
| ENSG00000271344.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.047113607 |
Resistant |
| ENSG00000271401.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.041991183 |
Resistant |
| ENSG00000271752.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.007573183 |
Resistant |
| ENSG00000271833.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.018434784 |
Resistant |
| ENSG00000272003.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.045104824 |
Resistant |
| ENSG00000272029.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.044299664 |
Resistant |
| ENSG00000272092.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.018998804 |
Resistant |
| ENSG00000272265.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.042813674 |
Resistant |
| ENSG00000272663.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.005631148 |
Resistant |
| ENSG00000272702.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.033265796 |
Resistant |
| ENSG00000272989.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.020531533 |
Resistant |
| ENSG00000273073.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.026762971 |
Resistant |
| ENSG00000273174.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.021471943 |
Resistant |
| ENSG00000273179.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.014829213 |
Resistant |
| ENSG00000273399.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.042871112 |
Resistant |
| ENSG00000172250.10 |
Crizotinib |
Brain lower grade glioma |
0.027646763 |
Resistant |
| ENSG00000185203.7 |
Crizotinib |
Brain lower grade glioma |
0.021767579 |
Resistant |
| ENSG00000188825.9 |
Crizotinib |
Brain lower grade glioma |
0.034593859 |
Resistant |
| ENSG00000205500.4 |
Crizotinib |
Brain lower grade glioma |
0.014220715 |
Resistant |
| ENSG00000214548.10 |
Crizotinib |
Brain lower grade glioma |
0.032390047 |
Resistant |
| ENSG00000223745.3 |
Crizotinib |
Brain lower grade glioma |
0.017140589 |
Resistant |
| ENSG00000223891.1 |
Crizotinib |
Brain lower grade glioma |
0.010700837 |
Resistant |
| ENSG00000224729.4 |
Crizotinib |
Brain lower grade glioma |
0.04712673 |
Resistant |
| ENSG00000224789.1 |
Crizotinib |
Brain lower grade glioma |
0.048224598 |
Resistant |
| ENSG00000225235.1 |
Crizotinib |
Brain lower grade glioma |
0.049981339 |
Resistant |
| ENSG00000225465.6 |
Crizotinib |
Brain lower grade glioma |
0.005922082 |
Resistant |
| ENSG00000226381.3 |
Crizotinib |
Brain lower grade glioma |
0.023512969 |
Resistant |
| ENSG00000226471.2 |
Crizotinib |
Brain lower grade glioma |
0.038992258 |
Resistant |
| ENSG00000227719.1 |
Crizotinib |
Brain lower grade glioma |
0.035143044 |
Resistant |
| ENSG00000228222.1 |
Crizotinib |
Brain lower grade glioma |
0.033949329 |
Resistant |
| ENSG00000228802.1 |
Crizotinib |
Brain lower grade glioma |
0.040066133 |
Resistant |
| ENSG00000228838.1 |
Crizotinib |
Brain lower grade glioma |
0.035756633 |
Resistant |
| ENSG00000229311.1 |
Crizotinib |
Brain lower grade glioma |
0.04969675 |
Resistant |
| ENSG00000229525.1 |
Crizotinib |
Brain lower grade glioma |
0.049159975 |
Resistant |
| ENSG00000229727.2 |
Crizotinib |
Brain lower grade glioma |
0.042515496 |
Resistant |
| ENSG00000230439.2 |
Crizotinib |
Brain lower grade glioma |
0.0093885 |
Resistant |
| ENSG00000230658.1 |
Crizotinib |
Brain lower grade glioma |
0.048245432 |
Resistant |
| ENSG00000230736.2 |
Crizotinib |
Brain lower grade glioma |
0.019859444 |
Resistant |
| ENSG00000230747.1 |
Crizotinib |
Brain lower grade glioma |
0.009650847 |
Resistant |
| ENSG00000231024.1 |
Crizotinib |
Brain lower grade glioma |
0.017157121 |
Resistant |
| ENSG00000231201.1 |
Crizotinib |
Brain lower grade glioma |
0.049144793 |
Resistant |
| ENSG00000231473.2 |
Crizotinib |
Brain lower grade glioma |
0.002243849 |
Resistant |
| ENSG00000231527.1 |
Crizotinib |
Brain lower grade glioma |
0.035530374 |
Resistant |
| ENSG00000231611.1 |
Crizotinib |
Brain lower grade glioma |
0.001827157 |
Resistant |
| ENSG00000231704.1 |
Crizotinib |
Brain lower grade glioma |
0.019189059 |
Resistant |
| ENSG00000231889.3 |
Crizotinib |
Brain lower grade glioma |
0.036448561 |
Resistant |
| ENSG00000231944.1 |
Crizotinib |
Brain lower grade glioma |
0.040846913 |
Resistant |
| ENSG00000232018.4 |
Crizotinib |
Brain lower grade glioma |
0.020837602 |
Resistant |
| ENSG00000232019.1 |
Crizotinib |
Brain lower grade glioma |
0.001853428 |
Resistant |
| ENSG00000232093.1 |
Crizotinib |
Brain lower grade glioma |
0.013796112 |
Resistant |
| ENSG00000232811.1 |
Crizotinib |
Brain lower grade glioma |
0.020796187 |
Resistant |
| ENSG00000232956.4 |
Crizotinib |
Brain lower grade glioma |
0.013419308 |
Resistant |
| ENSG00000233006.2 |
Crizotinib |
Brain lower grade glioma |
0.043827934 |
Resistant |
| ENSG00000234028.3 |
Crizotinib |
Brain lower grade glioma |
0.005668782 |
Resistant |
| ENSG00000234206.1 |
Crizotinib |
Brain lower grade glioma |
0.032902234 |
Resistant |
| ENSG00000234215.2 |
Crizotinib |
Brain lower grade glioma |
0.004462781 |
Resistant |
| ENSG00000234608.3 |
Crizotinib |
Brain lower grade glioma |
0.04998224 |
Resistant |
| ENSG00000235119.1 |
Crizotinib |
Brain lower grade glioma |
0.020365479 |
Resistant |
| ENSG00000235123.1 |
Crizotinib |
Brain lower grade glioma |
0.014802016 |
Resistant |
| ENSG00000235501.1 |
Crizotinib |
Brain lower grade glioma |
0.0211978 |
Resistant |
| ENSG00000235706.3 |
Crizotinib |
Brain lower grade glioma |
0.019533687 |
Resistant |
| ENSG00000235872.2 |
Crizotinib |
Brain lower grade glioma |
0.011152821 |
Resistant |
| ENSG00000235919.3 |
Crizotinib |
Brain lower grade glioma |
0.030254518 |
Resistant |
| ENSG00000236255.1 |
Crizotinib |
Brain lower grade glioma |
0.041135393 |
Resistant |
| ENSG00000236859.2 |
Crizotinib |
Brain lower grade glioma |
0.017699579 |
Resistant |
| ENSG00000237529.1 |
Crizotinib |
Brain lower grade glioma |
0.01907178 |
Resistant |
| ENSG00000239911.1 |
Crizotinib |
Brain lower grade glioma |
0.016109713 |
Resistant |
| ENSG00000240549.2 |
Crizotinib |
Brain lower grade glioma |
0.006124973 |
Resistant |
| ENSG00000241764.3 |
Crizotinib |
Brain lower grade glioma |
0.001706848 |
Resistant |
| ENSG00000241954.1 |
Crizotinib |
Brain lower grade glioma |
0.014391457 |
Resistant |
| ENSG00000244968.2 |
Crizotinib |
Brain lower grade glioma |
0.049458282 |
Resistant |
| ENSG00000245330.4 |
Crizotinib |
Brain lower grade glioma |
0.01204939 |
Resistant |
| ENSG00000247213.2 |
Crizotinib |
Brain lower grade glioma |
0.004661863 |
Resistant |
| ENSG00000249595.1 |
Crizotinib |
Brain lower grade glioma |
0.041166423 |
Resistant |
| ENSG00000250337.1 |
Crizotinib |
Brain lower grade glioma |
0.035247207 |
Resistant |
| ENSG00000251022.2 |
Crizotinib |
Brain lower grade glioma |
0.047121699 |
Resistant |
| ENSG00000253535.1 |
Crizotinib |
Brain lower grade glioma |
0.039521028 |
Resistant |
| ENSG00000253618.1 |
Crizotinib |
Brain lower grade glioma |
0.036993897 |
Resistant |
| ENSG00000253696.2 |
Crizotinib |
Brain lower grade glioma |
0.019168719 |
Resistant |
| ENSG00000253733.2 |
Crizotinib |
Brain lower grade glioma |
0.037696692 |
Resistant |
| ENSG00000253764.1 |
Crizotinib |
Brain lower grade glioma |
0.002972035 |
Resistant |
| ENSG00000253773.1 |
Crizotinib |
Brain lower grade glioma |
0.029224504 |
Resistant |
| ENSG00000254966.1 |
Crizotinib |
Brain lower grade glioma |
0.048780946 |
Resistant |
| ENSG00000255308.1 |
Crizotinib |
Brain lower grade glioma |
0.036937773 |
Resistant |
| ENSG00000255334.1 |
Crizotinib |
Brain lower grade glioma |
0.049114794 |
Resistant |
| ENSG00000256442.1 |
Crizotinib |
Brain lower grade glioma |
0.011428039 |
Resistant |
| ENSG00000256596.1 |
Crizotinib |
Brain lower grade glioma |
0.000331219 |
Resistant |
| ENSG00000256705.3 |
Crizotinib |
Brain lower grade glioma |
0.032942958 |
Resistant |
| ENSG00000257272.1 |
Crizotinib |
Brain lower grade glioma |
0.036046963 |
Resistant |
| ENSG00000257543.1 |
Crizotinib |
Brain lower grade glioma |
0.039942974 |
Resistant |
| ENSG00000257815.1 |
Crizotinib |
Brain lower grade glioma |
0.039078237 |
Resistant |
| ENSG00000258443.1 |
Crizotinib |
Brain lower grade glioma |
0.028771917 |
Resistant |
| ENSG00000258450.1 |
Crizotinib |
Brain lower grade glioma |
0.018296629 |
Resistant |
| ENSG00000258623.1 |
Crizotinib |
Brain lower grade glioma |
0.024015121 |
Resistant |
| ENSG00000258663.1 |
Crizotinib |
Brain lower grade glioma |
0.014198525 |
Resistant |
| ENSG00000258789.1 |
Crizotinib |
Brain lower grade glioma |
0.012137913 |
Resistant |
| ENSG00000259584.1 |
Crizotinib |
Brain lower grade glioma |
0.043117144 |
Resistant |
| ENSG00000259736.1 |
Crizotinib |
Brain lower grade glioma |
0.049314177 |
Resistant |
| ENSG00000259818.1 |
Crizotinib |
Brain lower grade glioma |
0.011650723 |
Resistant |
| ENSG00000259943.1 |
Crizotinib |
Brain lower grade glioma |
0.009253001 |
Resistant |
| ENSG00000260081.1 |
Crizotinib |
Brain lower grade glioma |
0.002708493 |
Resistant |
| ENSG00000260331.1 |
Crizotinib |
Brain lower grade glioma |
0.014975927 |
Resistant |
| ENSG00000260526.1 |
Crizotinib |
Brain lower grade glioma |
0.014673472 |
Resistant |
| ENSG00000260708.1 |
Crizotinib |
Brain lower grade glioma |
0.005636156 |
Resistant |
| ENSG00000260805.1 |
Crizotinib |
Brain lower grade glioma |
0.016359702 |
Resistant |
| ENSG00000260924.2 |
Crizotinib |
Brain lower grade glioma |
0.036086034 |
Resistant |
| ENSG00000260947.1 |
Crizotinib |
Brain lower grade glioma |
0.035303729 |
Resistant |
| ENSG00000261455.1 |
Crizotinib |
Brain lower grade glioma |
0.007371777 |
Resistant |
| ENSG00000261526.1 |
Crizotinib |
Brain lower grade glioma |
0.007284814 |
Resistant |
| ENSG00000261578.1 |
Crizotinib |
Brain lower grade glioma |
0.033335242 |
Resistant |
| ENSG00000261654.1 |
Crizotinib |
Brain lower grade glioma |
0.045118337 |
Resistant |
| ENSG00000263300.1 |
Crizotinib |
Brain lower grade glioma |
0.028945453 |
Resistant |
| ENSG00000264207.1 |
Crizotinib |
Brain lower grade glioma |
0.044149942 |
Resistant |
| ENSG00000264491.1 |
Crizotinib |
Brain lower grade glioma |
0.013554102 |
Resistant |
| ENSG00000265542.1 |
Crizotinib |
Brain lower grade glioma |
0.036805188 |
Resistant |
| ENSG00000265800.1 |
Crizotinib |
Brain lower grade glioma |
0.033237826 |
Resistant |
| ENSG00000266667.1 |
Crizotinib |
Brain lower grade glioma |
0.031468092 |
Resistant |
| ENSG00000266895.1 |
Crizotinib |
Brain lower grade glioma |
0.000814715 |
Resistant |
| ENSG00000267040.2 |
Crizotinib |
Brain lower grade glioma |
0.010941848 |
Resistant |
| ENSG00000267100.1 |
Crizotinib |
Brain lower grade glioma |
0.005677388 |
Resistant |
| ENSG00000267232.1 |
Crizotinib |
Brain lower grade glioma |
0.009509816 |
Resistant |
| ENSG00000267277.1 |
Crizotinib |
Brain lower grade glioma |
0.030984054 |
Resistant |
| ENSG00000267731.1 |
Crizotinib |
Brain lower grade glioma |
0.016260375 |
Resistant |
| ENSG00000267787.1 |
Crizotinib |
Brain lower grade glioma |
0.005703179 |
Resistant |
| ENSG00000269091.1 |
Crizotinib |
Brain lower grade glioma |
0.029553531 |
Resistant |
| ENSG00000269893.2 |
Crizotinib |
Brain lower grade glioma |
0.039806845 |
Resistant |
| ENSG00000269951.1 |
Crizotinib |
Brain lower grade glioma |
0.043699915 |
Resistant |
| ENSG00000270083.1 |
Crizotinib |
Brain lower grade glioma |
0.044976281 |
Resistant |
| ENSG00000270522.1 |
Crizotinib |
Brain lower grade glioma |
0.009835056 |
Resistant |
| ENSG00000270581.1 |
Crizotinib |
Brain lower grade glioma |
0.004683501 |
Resistant |
| ENSG00000270605.1 |
Crizotinib |
Brain lower grade glioma |
0.020644355 |
Resistant |
| ENSG00000270828.1 |
Crizotinib |
Brain lower grade glioma |
0.04409633 |
Resistant |
| ENSG00000270988.1 |
Crizotinib |
Brain lower grade glioma |
0.044309806 |
Resistant |
| ENSG00000271185.1 |
Crizotinib |
Brain lower grade glioma |
0.037256617 |
Resistant |
| ENSG00000271234.1 |
Crizotinib |
Brain lower grade glioma |
0.041213799 |
Resistant |
| ENSG00000271417.1 |
Crizotinib |
Brain lower grade glioma |
0.033029939 |
Resistant |
| ENSG00000271755.1 |
Crizotinib |
Brain lower grade glioma |
0.011320078 |
Resistant |
| ENSG00000271964.1 |
Crizotinib |
Brain lower grade glioma |
0.033430275 |
Resistant |
| ENSG00000272143.1 |
Crizotinib |
Brain lower grade glioma |
0.021438901 |
Resistant |
| ENSG00000272316.1 |
Crizotinib |
Brain lower grade glioma |
0.000176952 |
Resistant |
| ENSG00000272508.1 |
Crizotinib |
Brain lower grade glioma |
0.003087456 |
Resistant |
| ENSG00000272558.1 |
Crizotinib |
Brain lower grade glioma |
0.011383721 |
Resistant |
| ENSG00000272635.1 |
Crizotinib |
Brain lower grade glioma |
0.042334351 |
Resistant |
| ENSG00000272663.1 |
Crizotinib |
Brain lower grade glioma |
0.028207679 |
Resistant |
| ENSG00000272702.1 |
Crizotinib |
Brain lower grade glioma |
0.038117154 |
Resistant |
| ENSG00000272717.1 |
Crizotinib |
Brain lower grade glioma |
0.031673422 |
Resistant |
| ENSG00000272735.1 |
Crizotinib |
Brain lower grade glioma |
0.033028211 |
Resistant |
| ENSG00000272888.1 |
Crizotinib |
Brain lower grade glioma |
0.02040244 |
Resistant |
| ENSG00000272931.1 |
Crizotinib |
Brain lower grade glioma |
0.002209527 |
Resistant |
| ENSG00000273004.1 |
Crizotinib |
Brain lower grade glioma |
0.032550328 |
Resistant |
| ENSG00000273015.1 |
Crizotinib |
Brain lower grade glioma |
0.014547731 |
Resistant |
| ENSG00000273084.1 |
Crizotinib |
Brain lower grade glioma |
0.038892506 |
Resistant |
| ENSG00000273437.1 |
Crizotinib |
Brain lower grade glioma |
0.041925646 |
Resistant |
| ENSG00000273486.1 |
Crizotinib |
Brain lower grade glioma |
0.022627531 |
Resistant |
| ENSG00000178412.4 |
Crizotinib |
Lung squamous cell carcinoma |
0.019416627 |
Resistant |
| ENSG00000204934.6 |
Crizotinib |
Lung squamous cell carcinoma |
0.029205019 |
Resistant |
| ENSG00000223379.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.02894394 |
Resistant |
| ENSG00000224079.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.020077148 |
Resistant |
| ENSG00000225235.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.019683264 |
Resistant |
| ENSG00000225572.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.022140431 |
Resistant |
| ENSG00000225595.2 |
Crizotinib |
Lung squamous cell carcinoma |
0.040970201 |
Resistant |
| ENSG00000226200.2 |
Crizotinib |
Lung squamous cell carcinoma |
0.036131361 |
Resistant |
| ENSG00000226291.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.006372998 |
Resistant |
| ENSG00000229214.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.024470177 |
Resistant |
| ENSG00000230747.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.044671675 |
Resistant |
| ENSG00000230798.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.04551792 |
Resistant |
| ENSG00000230826.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.013163779 |
Resistant |
| ENSG00000231636.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.044839078 |
Resistant |
| ENSG00000231690.2 |
Crizotinib |
Lung squamous cell carcinoma |
0.016080227 |
Resistant |
| ENSG00000234264.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.033166874 |
Resistant |
| ENSG00000235659.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.036676643 |
Resistant |
| ENSG00000236173.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.031851049 |
Resistant |
| ENSG00000237892.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.02350694 |
Resistant |
| ENSG00000246363.2 |
Crizotinib |
Lung squamous cell carcinoma |
0.048336462 |
Resistant |
| ENSG00000254315.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.029785377 |
Resistant |
| ENSG00000254821.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.035670747 |
Resistant |
| ENSG00000256008.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.038433765 |
Resistant |
| ENSG00000256250.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.031851338 |
Resistant |
| ENSG00000256299.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.045702324 |
Resistant |
| ENSG00000256897.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.032231157 |
Resistant |
| ENSG00000257711.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.04743328 |
Resistant |
| ENSG00000260060.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.032392761 |
Resistant |
| ENSG00000260063.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.02373089 |
Resistant |
| ENSG00000262202.3 |
Crizotinib |
Lung squamous cell carcinoma |
0.042146646 |
Resistant |
| ENSG00000262228.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.044623394 |
Resistant |
| ENSG00000262339.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.020958934 |
Resistant |
| ENSG00000264167.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.021632465 |
Resistant |
| ENSG00000264247.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.030248382 |
Resistant |
| ENSG00000266579.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.027627658 |
Resistant |
| ENSG00000266844.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.000419488 |
Resistant |
| ENSG00000270742.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.002307174 |
Resistant |
| ENSG00000271981.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.038799684 |
Resistant |
| ENSG00000272871.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.043276397 |
Resistant |
| ENSG00000272966.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.013012127 |
Resistant |
| ENSG00000223697.2 |
Crizotinib |
Skin cutaneous melanoma |
0.014615846 |
Resistant |
| ENSG00000225490.1 |
Crizotinib |
Skin cutaneous melanoma |
0.041856119 |
Resistant |
| ENSG00000225703.1 |
Crizotinib |
Skin cutaneous melanoma |
0.049363026 |
Resistant |
| ENSG00000226245.1 |
Crizotinib |
Skin cutaneous melanoma |
0.028584131 |
Resistant |
| ENSG00000227719.1 |
Crizotinib |
Skin cutaneous melanoma |
0.049200779 |
Resistant |
| ENSG00000228784.3 |
Crizotinib |
Skin cutaneous melanoma |
0.0479332 |
Resistant |
| ENSG00000230912.1 |
Crizotinib |
Skin cutaneous melanoma |
0.027240828 |
Resistant |
| ENSG00000230943.1 |
Crizotinib |
Skin cutaneous melanoma |
0.037699384 |
Resistant |
| ENSG00000231355.1 |
Crizotinib |
Skin cutaneous melanoma |
0.014983305 |
Resistant |
| ENSG00000231709.1 |
Crizotinib |
Skin cutaneous melanoma |
0.047389191 |
Resistant |
| ENSG00000232065.1 |
Crizotinib |
Skin cutaneous melanoma |
0.015203655 |
Resistant |
| ENSG00000232412.1 |
Crizotinib |
Skin cutaneous melanoma |
0.019305974 |
Resistant |
| ENSG00000233895.1 |
Crizotinib |
Skin cutaneous melanoma |
0.027607384 |
Resistant |
| ENSG00000234432.3 |
Crizotinib |
Skin cutaneous melanoma |
0.03546095 |
Resistant |
| ENSG00000234492.4 |
Crizotinib |
Skin cutaneous melanoma |
0.01510476 |
Resistant |
| ENSG00000235652.3 |
Crizotinib |
Skin cutaneous melanoma |
0.048461703 |
Resistant |
| ENSG00000236166.1 |
Crizotinib |
Skin cutaneous melanoma |
0.012656507 |
Resistant |
| ENSG00000240859.1 |
Crizotinib |
Skin cutaneous melanoma |
0.032662133 |
Resistant |
| ENSG00000243766.3 |
Crizotinib |
Skin cutaneous melanoma |
0.039304052 |
Resistant |
| ENSG00000245534.2 |
Crizotinib |
Skin cutaneous melanoma |
0.038573613 |
Resistant |
| ENSG00000248896.2 |
Crizotinib |
Skin cutaneous melanoma |
0.049297747 |
Resistant |
| ENSG00000250404.1 |
Crizotinib |
Skin cutaneous melanoma |
0.009630543 |
Resistant |
| ENSG00000250948.1 |
Crizotinib |
Skin cutaneous melanoma |
0.001945873 |
Resistant |
| ENSG00000258410.1 |
Crizotinib |
Skin cutaneous melanoma |
0.028238168 |
Resistant |
| ENSG00000259065.1 |
Crizotinib |
Skin cutaneous melanoma |
0.029268499 |
Resistant |
| ENSG00000259244.1 |
Crizotinib |
Skin cutaneous melanoma |
0.013978697 |
Resistant |
| ENSG00000259668.1 |
Crizotinib |
Skin cutaneous melanoma |
0.028564688 |
Resistant |
| ENSG00000261572.1 |
Crizotinib |
Skin cutaneous melanoma |
0.010412184 |
Resistant |
| ENSG00000262298.1 |
Crizotinib |
Skin cutaneous melanoma |
0.027043942 |
Resistant |
| ENSG00000264940.2 |
Crizotinib |
Skin cutaneous melanoma |
0.021244073 |
Resistant |
| ENSG00000267344.1 |
Crizotinib |
Skin cutaneous melanoma |
0.020471255 |
Resistant |
| ENSG00000271840.1 |
Crizotinib |
Skin cutaneous melanoma |
0.02701228 |
Resistant |
| ENSG00000272009.1 |
Crizotinib |
Skin cutaneous melanoma |
0.018261538 |
Resistant |
| ENSG00000272338.1 |
Crizotinib |
Skin cutaneous melanoma |
0.0000932 |
Resistant |
| ENSG00000163364.5 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040347805 |
Sensitive |
| ENSG00000225206.4 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035943066 |
Sensitive |
| ENSG00000232542.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016701785 |
Sensitive |
| ENSG00000254237.1 |
Crizotinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027407664 |
Sensitive |
| ENSG00000223946.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.030964664 |
Sensitive |
| ENSG00000225742.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.034618073 |
Sensitive |
| ENSG00000225761.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.032000567 |
Sensitive |
| ENSG00000227256.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.010438144 |
Sensitive |
| ENSG00000228629.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.032290971 |
Sensitive |
| ENSG00000228634.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.023996876 |
Sensitive |
| ENSG00000229190.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.043773095 |
Sensitive |
| ENSG00000230046.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.04750355 |
Sensitive |
| ENSG00000232162.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.034101574 |
Sensitive |
| ENSG00000232406.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.012353972 |
Sensitive |
| ENSG00000233848.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.007824059 |
Sensitive |
| ENSG00000237200.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.042073304 |
Sensitive |
| ENSG00000239552.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.031754708 |
Sensitive |
| ENSG00000242147.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.01749181 |
Sensitive |
| ENSG00000243485.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.035652412 |
Sensitive |
| ENSG00000244300.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.044024761 |
Sensitive |
| ENSG00000244468.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.044679747 |
Sensitive |
| ENSG00000246263.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.032734954 |
Sensitive |
| ENSG00000249602.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.023436783 |
Sensitive |
| ENSG00000249816.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.045004484 |
Sensitive |
| ENSG00000250027.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.014507438 |
Sensitive |
| ENSG00000250751.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.008006018 |
Sensitive |
| ENSG00000254477.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.048906533 |
Sensitive |
| ENSG00000256712.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.021500665 |
Sensitive |
| ENSG00000259366.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.017519801 |
Sensitive |
| ENSG00000259553.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.042094645 |
Sensitive |
| ENSG00000259617.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.036336392 |
Sensitive |
| ENSG00000261754.2 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.035248227 |
Sensitive |
| ENSG00000262098.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.018841559 |
Sensitive |
| ENSG00000262171.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.03408381 |
Sensitive |
| ENSG00000262873.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.02109471 |
Sensitive |
| ENSG00000264112.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.021599361 |
Sensitive |
| ENSG00000264339.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.038159674 |
Sensitive |
| ENSG00000264635.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.030429213 |
Sensitive |
| ENSG00000267265.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.032755456 |
Sensitive |
| ENSG00000267416.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.033783903 |
Sensitive |
| ENSG00000268316.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.028365134 |
Sensitive |
| ENSG00000271382.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.016937734 |
Sensitive |
| ENSG00000272248.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.044329197 |
Sensitive |
| ENSG00000272691.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.036692879 |
Sensitive |
| ENSG00000272812.1 |
Crizotinib |
Chronic Lymphocytic Leukemia |
0.010680065 |
Sensitive |
| ENSG00000177337.3 |
Crizotinib |
Brain lower grade glioma |
0.017354107 |
Sensitive |
| ENSG00000189149.7 |
Crizotinib |
Brain lower grade glioma |
0.042733911 |
Sensitive |
| ENSG00000224023.6 |
Crizotinib |
Brain lower grade glioma |
0.03885667 |
Sensitive |
| ENSG00000224216.1 |
Crizotinib |
Brain lower grade glioma |
0.011614362 |
Sensitive |
| ENSG00000225981.1 |
Crizotinib |
Brain lower grade glioma |
0.025355487 |
Sensitive |
| ENSG00000226747.2 |
Crizotinib |
Brain lower grade glioma |
0.042154152 |
Sensitive |
| ENSG00000227214.2 |
Crizotinib |
Brain lower grade glioma |
0.000421045 |
Sensitive |
| ENSG00000228412.2 |
Crizotinib |
Brain lower grade glioma |
0.000703569 |
Sensitive |
| ENSG00000229702.1 |
Crizotinib |
Brain lower grade glioma |
0.007291222 |
Sensitive |
| ENSG00000229952.1 |
Crizotinib |
Brain lower grade glioma |
0.016984774 |
Sensitive |
| ENSG00000230628.1 |
Crizotinib |
Brain lower grade glioma |
0.025477907 |
Sensitive |
| ENSG00000230630.1 |
Crizotinib |
Brain lower grade glioma |
0.026500427 |
Sensitive |
| ENSG00000231890.3 |
Crizotinib |
Brain lower grade glioma |
0.033041627 |
Sensitive |
| ENSG00000232642.1 |
Crizotinib |
Brain lower grade glioma |
0.04510062 |
Sensitive |
| ENSG00000232725.1 |
Crizotinib |
Brain lower grade glioma |
0.020647973 |
Sensitive |
| ENSG00000233903.2 |
Crizotinib |
Brain lower grade glioma |
0.015584622 |
Sensitive |
| ENSG00000234232.2 |
Crizotinib |
Brain lower grade glioma |
0.048484883 |
Sensitive |
| ENSG00000237525.2 |
Crizotinib |
Brain lower grade glioma |
0.032419437 |
Sensitive |
| ENSG00000238121.1 |
Crizotinib |
Brain lower grade glioma |
0.024733002 |
Sensitive |
| ENSG00000244203.2 |
Crizotinib |
Brain lower grade glioma |
0.044206007 |
Sensitive |
| ENSG00000244349.1 |
Crizotinib |
Brain lower grade glioma |
0.027123292 |
Sensitive |
| ENSG00000245479.2 |
Crizotinib |
Brain lower grade glioma |
0.018151656 |
Sensitive |
| ENSG00000248008.2 |
Crizotinib |
Brain lower grade glioma |
0.012421923 |
Sensitive |
| ENSG00000248677.1 |
Crizotinib |
Brain lower grade glioma |
0.041877997 |
Sensitive |
| ENSG00000249628.2 |
Crizotinib |
Brain lower grade glioma |
0.034647686 |
Sensitive |
| ENSG00000251136.4 |
Crizotinib |
Brain lower grade glioma |
0.034021662 |
Sensitive |
| ENSG00000253190.2 |
Crizotinib |
Brain lower grade glioma |
0.037287739 |
Sensitive |
| ENSG00000254258.1 |
Crizotinib |
Brain lower grade glioma |
0.040562751 |
Sensitive |
| ENSG00000254295.1 |
Crizotinib |
Brain lower grade glioma |
0.035395815 |
Sensitive |
| ENSG00000255197.1 |
Crizotinib |
Brain lower grade glioma |
0.028082238 |
Sensitive |
| ENSG00000258777.1 |
Crizotinib |
Brain lower grade glioma |
0.042926509 |
Sensitive |
| ENSG00000258929.2 |
Crizotinib |
Brain lower grade glioma |
0.018297212 |
Sensitive |
| ENSG00000259212.1 |
Crizotinib |
Brain lower grade glioma |
0.035728837 |
Sensitive |
| ENSG00000260552.1 |
Crizotinib |
Brain lower grade glioma |
0.04518526 |
Sensitive |
| ENSG00000260630.2 |
Crizotinib |
Brain lower grade glioma |
0.002402841 |
Sensitive |
| ENSG00000260693.1 |
Crizotinib |
Brain lower grade glioma |
0.041348873 |
Sensitive |
| ENSG00000260911.1 |
Crizotinib |
Brain lower grade glioma |
0.025980436 |
Sensitive |
| ENSG00000261253.1 |
Crizotinib |
Brain lower grade glioma |
0.042885531 |
Sensitive |
| ENSG00000261616.1 |
Crizotinib |
Brain lower grade glioma |
0.045198751 |
Sensitive |
| ENSG00000261712.1 |
Crizotinib |
Brain lower grade glioma |
0.039912196 |
Sensitive |
| ENSG00000262185.1 |
Crizotinib |
Brain lower grade glioma |
0.038674408 |
Sensitive |
| ENSG00000262777.1 |
Crizotinib |
Brain lower grade glioma |
0.044165023 |
Sensitive |
| ENSG00000262903.1 |
Crizotinib |
Brain lower grade glioma |
0.002473826 |
Sensitive |
| ENSG00000262999.1 |
Crizotinib |
Brain lower grade glioma |
0.032784762 |
Sensitive |
| ENSG00000266930.2 |
Crizotinib |
Brain lower grade glioma |
0.002795405 |
Sensitive |
| ENSG00000267395.1 |
Crizotinib |
Brain lower grade glioma |
0.008893974 |
Sensitive |
| ENSG00000271762.1 |
Crizotinib |
Brain lower grade glioma |
0.015763971 |
Sensitive |
| ENSG00000271882.1 |
Crizotinib |
Brain lower grade glioma |
0.01853749 |
Sensitive |
| ENSG00000272142.1 |
Crizotinib |
Brain lower grade glioma |
0.042185445 |
Sensitive |
| ENSG00000272377.1 |
Crizotinib |
Brain lower grade glioma |
0.022287733 |
Sensitive |
| ENSG00000272420.1 |
Crizotinib |
Brain lower grade glioma |
0.036658727 |
Sensitive |
| ENSG00000273065.1 |
Crizotinib |
Brain lower grade glioma |
0.034607515 |
Sensitive |
| ENSG00000273071.1 |
Crizotinib |
Brain lower grade glioma |
0.047636144 |
Sensitive |
| ENSG00000170919.11 |
Crizotinib |
Lung squamous cell carcinoma |
0.015718212 |
Sensitive |
| ENSG00000197670.5 |
Crizotinib |
Lung squamous cell carcinoma |
0.021919792 |
Sensitive |
| ENSG00000204380.2 |
Crizotinib |
Lung squamous cell carcinoma |
0.00000304 |
Sensitive |
| ENSG00000213904.4 |
Crizotinib |
Lung squamous cell carcinoma |
0.009674142 |
Sensitive |
| ENSG00000221817.5 |
Crizotinib |
Lung squamous cell carcinoma |
0.000225492 |
Sensitive |
| ENSG00000222044.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.033324072 |
Sensitive |
| ENSG00000223695.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.022642837 |
Sensitive |
| ENSG00000224269.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.010320864 |
Sensitive |
| ENSG00000224707.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.034307722 |
Sensitive |
| ENSG00000224764.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.001018726 |
Sensitive |
| ENSG00000224969.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.028434193 |
Sensitive |
| ENSG00000225331.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.03230669 |
Sensitive |
| ENSG00000225703.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.014029043 |
Sensitive |
| ENSG00000228107.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.00589131 |
Sensitive |
| ENSG00000228812.3 |
Crizotinib |
Lung squamous cell carcinoma |
0.012030985 |
Sensitive |
| ENSG00000229463.2 |
Crizotinib |
Lung squamous cell carcinoma |
0.010200228 |
Sensitive |
| ENSG00000229618.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.030600134 |
Sensitive |
| ENSG00000229951.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.002876357 |
Sensitive |
| ENSG00000232480.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.020486786 |
Sensitive |
| ENSG00000232564.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.038444079 |
Sensitive |
| ENSG00000232623.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.044805617 |
Sensitive |
| ENSG00000232694.2 |
Crizotinib |
Lung squamous cell carcinoma |
0.025003736 |
Sensitive |
| ENSG00000233006.2 |
Crizotinib |
Lung squamous cell carcinoma |
0.016383166 |
Sensitive |
| ENSG00000233547.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.04103468 |
Sensitive |
| ENSG00000234290.2 |
Crizotinib |
Lung squamous cell carcinoma |
0.042647741 |
Sensitive |
| ENSG00000234509.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.029339315 |
Sensitive |
| ENSG00000235703.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.023407144 |
Sensitive |
| ENSG00000236658.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.03158941 |
Sensitive |
| ENSG00000236751.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.007969974 |
Sensitive |
| ENSG00000240006.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.039292315 |
Sensitive |
| ENSG00000240373.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.038954252 |
Sensitive |
| ENSG00000244310.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.012643696 |
Sensitive |
| ENSG00000245275.3 |
Crizotinib |
Lung squamous cell carcinoma |
0.047745062 |
Sensitive |
| ENSG00000248223.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.043372607 |
Sensitive |
| ENSG00000248356.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.023893184 |
Sensitive |
| ENSG00000248468.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.002966142 |
Sensitive |
| ENSG00000249740.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.028936637 |
Sensitive |
| ENSG00000253948.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.018951344 |
Sensitive |
| ENSG00000254418.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.004751316 |
Sensitive |
| ENSG00000254485.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.048088001 |
Sensitive |
| ENSG00000255092.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.017639444 |
Sensitive |
| ENSG00000255980.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.003107873 |
Sensitive |
| ENSG00000256789.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.003750369 |
Sensitive |
| ENSG00000257433.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.032980313 |
Sensitive |
| ENSG00000257438.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.026950526 |
Sensitive |
| ENSG00000257474.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.012151822 |
Sensitive |
| ENSG00000258188.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.017175172 |
Sensitive |
| ENSG00000258458.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.012949692 |
Sensitive |
| ENSG00000258521.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.047076729 |
Sensitive |
| ENSG00000259158.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.035522278 |
Sensitive |
| ENSG00000259198.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.049241404 |
Sensitive |
| ENSG00000259200.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.009855106 |
Sensitive |
| ENSG00000259644.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.042718606 |
Sensitive |
| ENSG00000260197.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.03789185 |
Sensitive |
| ENSG00000260613.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.000351164 |
Sensitive |
| ENSG00000260633.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.025101443 |
Sensitive |
| ENSG00000260896.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.01243495 |
Sensitive |
| ENSG00000261212.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.016530643 |
Sensitive |
| ENSG00000263466.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.032157086 |
Sensitive |
| ENSG00000263612.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.042871776 |
Sensitive |
| ENSG00000263874.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.046077714 |
Sensitive |
| ENSG00000264729.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.024807107 |
Sensitive |
| ENSG00000265519.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.038245028 |
Sensitive |
| ENSG00000265739.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.012698649 |
Sensitive |
| ENSG00000266079.2 |
Crizotinib |
Lung squamous cell carcinoma |
0.004564853 |
Sensitive |
| ENSG00000266908.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.042569212 |
Sensitive |
| ENSG00000267219.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.007265884 |
Sensitive |
| ENSG00000267446.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.003449138 |
Sensitive |
| ENSG00000268366.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.004160569 |
Sensitive |
| ENSG00000269051.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.02178216 |
Sensitive |
| ENSG00000269246.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.034881358 |
Sensitive |
| ENSG00000269392.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.010640628 |
Sensitive |
| ENSG00000269956.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.012007835 |
Sensitive |
| ENSG00000273297.1 |
Crizotinib |
Lung squamous cell carcinoma |
0.034042968 |
Sensitive |
| ENSG00000177822.3 |
Crizotinib |
Skin cutaneous melanoma |
0.006547463 |
Sensitive |
| ENSG00000187156.4 |
Crizotinib |
Skin cutaneous melanoma |
0.036268405 |
Sensitive |
| ENSG00000203593.3 |
Crizotinib |
Skin cutaneous melanoma |
0.012785818 |
Sensitive |
| ENSG00000203808.6 |
Crizotinib |
Skin cutaneous melanoma |
0.025322728 |
Sensitive |
| ENSG00000204791.4 |
Crizotinib |
Skin cutaneous melanoma |
0.034340327 |
Sensitive |
| ENSG00000223834.2 |
Crizotinib |
Skin cutaneous melanoma |
0.013356347 |
Sensitive |
| ENSG00000224707.1 |
Crizotinib |
Skin cutaneous melanoma |
0.045443576 |
Sensitive |
| ENSG00000224950.1 |
Crizotinib |
Skin cutaneous melanoma |
0.039954433 |
Sensitive |
| ENSG00000224977.1 |
Crizotinib |
Skin cutaneous melanoma |
0.017407793 |
Sensitive |
| ENSG00000226381.3 |
Crizotinib |
Skin cutaneous melanoma |
0.030653376 |
Sensitive |
| ENSG00000226609.1 |
Crizotinib |
Skin cutaneous melanoma |
0.042615495 |
Sensitive |
| ENSG00000226889.3 |
Crizotinib |
Skin cutaneous melanoma |
0.019565718 |
Sensitive |
| ENSG00000227297.1 |
Crizotinib |
Skin cutaneous melanoma |
0.0118314 |
Sensitive |
| ENSG00000227542.1 |
Crizotinib |
Skin cutaneous melanoma |
0.030588312 |
Sensitive |
| ENSG00000227698.1 |
Crizotinib |
Skin cutaneous melanoma |
0.023424562 |
Sensitive |
| ENSG00000228369.2 |
Crizotinib |
Skin cutaneous melanoma |
0.028875589 |
Sensitive |
| ENSG00000228540.1 |
Crizotinib |
Skin cutaneous melanoma |
0.027609389 |
Sensitive |
| ENSG00000228573.1 |
Crizotinib |
Skin cutaneous melanoma |
0.048609662 |
Sensitive |
| ENSG00000229263.1 |
Crizotinib |
Skin cutaneous melanoma |
0.034349316 |
Sensitive |
| ENSG00000229331.1 |
Crizotinib |
Skin cutaneous melanoma |
0.02673764 |
Sensitive |
| ENSG00000229867.1 |
Crizotinib |
Skin cutaneous melanoma |
0.047547728 |
Sensitive |
| ENSG00000230131.1 |
Crizotinib |
Skin cutaneous melanoma |
0.003035882 |
Sensitive |
| ENSG00000231187.2 |
Crizotinib |
Skin cutaneous melanoma |
0.027935138 |
Sensitive |
| ENSG00000231242.1 |
Crizotinib |
Skin cutaneous melanoma |
0.039189035 |
Sensitive |
| ENSG00000231298.2 |
Crizotinib |
Skin cutaneous melanoma |
0.017689265 |
Sensitive |
| ENSG00000231566.1 |
Crizotinib |
Skin cutaneous melanoma |
0.049700452 |
Sensitive |
| ENSG00000232211.1 |
Crizotinib |
Skin cutaneous melanoma |
0.021823268 |
Sensitive |
| ENSG00000232586.1 |
Crizotinib |
Skin cutaneous melanoma |
0.015596092 |
Sensitive |
| ENSG00000233757.2 |
Crizotinib |
Skin cutaneous melanoma |
0.004835448 |
Sensitive |
| ENSG00000234171.1 |
Crizotinib |
Skin cutaneous melanoma |
0.039124502 |
Sensitive |
| ENSG00000235070.3 |
Crizotinib |
Skin cutaneous melanoma |
0.0162571 |
Sensitive |
| ENSG00000235078.1 |
Crizotinib |
Skin cutaneous melanoma |
0.004155806 |
Sensitive |
| ENSG00000235358.1 |
Crizotinib |
Skin cutaneous melanoma |
0.020290477 |
Sensitive |
| ENSG00000235387.1 |
Crizotinib |
Skin cutaneous melanoma |
0.017439243 |
Sensitive |
| ENSG00000235781.1 |
Crizotinib |
Skin cutaneous melanoma |
0.034172747 |
Sensitive |
| ENSG00000236088.5 |
Crizotinib |
Skin cutaneous melanoma |
0.049019204 |
Sensitive |
| ENSG00000236751.1 |
Crizotinib |
Skin cutaneous melanoma |
0.008559469 |
Sensitive |
| ENSG00000237125.4 |
Crizotinib |
Skin cutaneous melanoma |
0.036265259 |
Sensitive |
| ENSG00000237870.2 |
Crizotinib |
Skin cutaneous melanoma |
0.027462451 |
Sensitive |
| ENSG00000239523.1 |
Crizotinib |
Skin cutaneous melanoma |
0.001415762 |
Sensitive |
| ENSG00000240618.1 |
Crizotinib |
Skin cutaneous melanoma |
0.042637403 |
Sensitive |
| ENSG00000244265.1 |
Crizotinib |
Skin cutaneous melanoma |
0.036847552 |
Sensitive |
| ENSG00000244586.1 |
Crizotinib |
Skin cutaneous melanoma |
0.0001416 |
Sensitive |
| ENSG00000247092.2 |
Crizotinib |
Skin cutaneous melanoma |
0.039333374 |
Sensitive |
| ENSG00000247774.2 |
Crizotinib |
Skin cutaneous melanoma |
0.022513345 |
Sensitive |
| ENSG00000248103.1 |
Crizotinib |
Skin cutaneous melanoma |
0.020477819 |
Sensitive |
| ENSG00000248858.3 |
Crizotinib |
Skin cutaneous melanoma |
0.013075203 |
Sensitive |
| ENSG00000248927.1 |
Crizotinib |
Skin cutaneous melanoma |
0.022362803 |
Sensitive |
| ENSG00000249198.1 |
Crizotinib |
Skin cutaneous melanoma |
0.029160429 |
Sensitive |
| ENSG00000249436.1 |
Crizotinib |
Skin cutaneous melanoma |
0.034758703 |
Sensitive |
| ENSG00000249740.1 |
Crizotinib |
Skin cutaneous melanoma |
0.006405928 |
Sensitive |
| ENSG00000250295.2 |
Crizotinib |
Skin cutaneous melanoma |
0.013622705 |
Sensitive |
| ENSG00000250659.2 |
Crizotinib |
Skin cutaneous melanoma |
0.0258181 |
Sensitive |
| ENSG00000251127.2 |
Crizotinib |
Skin cutaneous melanoma |
0.009612871 |
Sensitive |
| ENSG00000251556.1 |
Crizotinib |
Skin cutaneous melanoma |
0.035389393 |
Sensitive |
| ENSG00000251629.2 |
Crizotinib |
Skin cutaneous melanoma |
0.02843345 |
Sensitive |
| ENSG00000253121.1 |
Crizotinib |
Skin cutaneous melanoma |
0.007485197 |
Sensitive |
| ENSG00000254401.1 |
Crizotinib |
Skin cutaneous melanoma |
0.01894529 |
Sensitive |
| ENSG00000254842.2 |
Crizotinib |
Skin cutaneous melanoma |
0.047852298 |
Sensitive |
| ENSG00000254859.1 |
Crizotinib |
Skin cutaneous melanoma |
0.048072324 |
Sensitive |
| ENSG00000254966.1 |
Crizotinib |
Skin cutaneous melanoma |
0.005070527 |
Sensitive |
| ENSG00000255354.1 |
Crizotinib |
Skin cutaneous melanoma |
0.030855332 |
Sensitive |
| ENSG00000256001.1 |
Crizotinib |
Skin cutaneous melanoma |
0.042424939 |
Sensitive |
| ENSG00000256712.1 |
Crizotinib |
Skin cutaneous melanoma |
0.042118079 |
Sensitive |
| ENSG00000256967.1 |
Crizotinib |
Skin cutaneous melanoma |
0.037402065 |
Sensitive |
| ENSG00000257900.2 |
Crizotinib |
Skin cutaneous melanoma |
0.006252442 |
Sensitive |
| ENSG00000257910.1 |
Crizotinib |
Skin cutaneous melanoma |
0.035042702 |
Sensitive |
| ENSG00000257931.2 |
Crizotinib |
Skin cutaneous melanoma |
0.038890491 |
Sensitive |
| ENSG00000258314.2 |
Crizotinib |
Skin cutaneous melanoma |
0.000248291 |
Sensitive |
| ENSG00000258317.1 |
Crizotinib |
Skin cutaneous melanoma |
0.006104396 |
Sensitive |
| ENSG00000258437.1 |
Crizotinib |
Skin cutaneous melanoma |
0.012335755 |
Sensitive |
| ENSG00000258558.1 |
Crizotinib |
Skin cutaneous melanoma |
0.019409488 |
Sensitive |
| ENSG00000258851.1 |
Crizotinib |
Skin cutaneous melanoma |
0.020457557 |
Sensitive |
| ENSG00000258942.1 |
Crizotinib |
Skin cutaneous melanoma |
0.01436738 |
Sensitive |
| ENSG00000259062.1 |
Crizotinib |
Skin cutaneous melanoma |
0.028628317 |
Sensitive |
| ENSG00000259786.2 |
Crizotinib |
Skin cutaneous melanoma |
0.014727849 |
Sensitive |
| ENSG00000260083.1 |
Crizotinib |
Skin cutaneous melanoma |
0.017867162 |
Sensitive |
| ENSG00000260158.1 |
Crizotinib |
Skin cutaneous melanoma |
0.043070279 |
Sensitive |
| ENSG00000260475.1 |
Crizotinib |
Skin cutaneous melanoma |
0.025694402 |
Sensitive |
| ENSG00000260597.1 |
Crizotinib |
Skin cutaneous melanoma |
0.010278932 |
Sensitive |
| ENSG00000260938.1 |
Crizotinib |
Skin cutaneous melanoma |
0.048716349 |
Sensitive |
| ENSG00000261043.2 |
Crizotinib |
Skin cutaneous melanoma |
0.020952571 |
Sensitive |
| ENSG00000261251.1 |
Crizotinib |
Skin cutaneous melanoma |
0.02996326 |
Sensitive |
| ENSG00000261327.3 |
Crizotinib |
Skin cutaneous melanoma |
0.047212029 |
Sensitive |
| ENSG00000261433.1 |
Crizotinib |
Skin cutaneous melanoma |
0.007561042 |
Sensitive |
| ENSG00000261471.1 |
Crizotinib |
Skin cutaneous melanoma |
0.044097542 |
Sensitive |
| ENSG00000262185.1 |
Crizotinib |
Skin cutaneous melanoma |
0.007633539 |
Sensitive |
| ENSG00000263745.1 |
Crizotinib |
Skin cutaneous melanoma |
0.011951014 |
Sensitive |
| ENSG00000263884.1 |
Crizotinib |
Skin cutaneous melanoma |
0.049242161 |
Sensitive |
| ENSG00000264448.2 |
Crizotinib |
Skin cutaneous melanoma |
0.014622416 |
Sensitive |
| ENSG00000265394.1 |
Crizotinib |
Skin cutaneous melanoma |
0.041670224 |
Sensitive |
| ENSG00000265445.1 |
Crizotinib |
Skin cutaneous melanoma |
0.011597416 |
Sensitive |
| ENSG00000265780.1 |
Crizotinib |
Skin cutaneous melanoma |
0.00770144 |
Sensitive |
| ENSG00000267053.2 |
Crizotinib |
Skin cutaneous melanoma |
0.009098332 |
Sensitive |
| ENSG00000267067.1 |
Crizotinib |
Skin cutaneous melanoma |
0.028898593 |
Sensitive |
| ENSG00000267298.1 |
Crizotinib |
Skin cutaneous melanoma |
0.006324557 |
Sensitive |
| ENSG00000267348.2 |
Crizotinib |
Skin cutaneous melanoma |
0.037153029 |
Sensitive |
| ENSG00000267759.1 |
Crizotinib |
Skin cutaneous melanoma |
0.007082875 |
Sensitive |
| ENSG00000267898.1 |
Crizotinib |
Skin cutaneous melanoma |
0.028922471 |
Sensitive |
| ENSG00000268746.1 |
Crizotinib |
Skin cutaneous melanoma |
0.028465448 |
Sensitive |
| ENSG00000268987.1 |
Crizotinib |
Skin cutaneous melanoma |
0.041867347 |
Sensitive |
| ENSG00000269161.1 |
Crizotinib |
Skin cutaneous melanoma |
0.026697735 |
Sensitive |
| ENSG00000269194.1 |
Crizotinib |
Skin cutaneous melanoma |
0.032087628 |
Sensitive |
| ENSG00000269399.1 |
Crizotinib |
Skin cutaneous melanoma |
0.004798962 |
Sensitive |
| ENSG00000269959.1 |
Crizotinib |
Skin cutaneous melanoma |
0.002935145 |
Sensitive |
| ENSG00000269966.1 |
Crizotinib |
Skin cutaneous melanoma |
0.017765267 |
Sensitive |
| ENSG00000271788.1 |
Crizotinib |
Skin cutaneous melanoma |
0.013294406 |
Sensitive |
| ENSG00000271825.1 |
Crizotinib |
Skin cutaneous melanoma |
0.039417851 |
Sensitive |
| ENSG00000272102.1 |
Crizotinib |
Skin cutaneous melanoma |
0.010637227 |
Sensitive |
| ENSG00000272254.1 |
Crizotinib |
Skin cutaneous melanoma |
0.033472369 |
Sensitive |
| ENSG00000272327.1 |
Crizotinib |
Skin cutaneous melanoma |
0.000188025 |
Sensitive |
| ENSG00000272461.1 |
Crizotinib |
Skin cutaneous melanoma |
0.015981074 |
Sensitive |
| ENSG00000272524.1 |
Crizotinib |
Skin cutaneous melanoma |
0.021725828 |
Sensitive |
| ENSG00000272562.1 |
Crizotinib |
Skin cutaneous melanoma |
0.010172086 |
Sensitive |
| ENSG00000272695.1 |
Crizotinib |
Skin cutaneous melanoma |
0.0009507 |
Sensitive |
| ENSG00000272702.1 |
Crizotinib |
Skin cutaneous melanoma |
0.004388924 |
Sensitive |
| ENSG00000272966.1 |
Crizotinib |
Skin cutaneous melanoma |
0.043524243 |
Sensitive |
| ENSG00000273230.1 |
Crizotinib |
Skin cutaneous melanoma |
0.014877086 |
Sensitive |
| ENSG00000273309.1 |
Crizotinib |
Skin cutaneous melanoma |
0.034317136 |
Sensitive |
